Zymeworks, Inc. (ZYME)
28.87
+0.02
(+0.07%)
USD |
NASDAQ |
Oct 28, 16:00
28.87
0.00 (0.00%)
After-Hours: 16:00
Zymeworks Market Cap : 2.078B for Oct. 28, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 27, 2026 | 2.076B |
| October 26, 2026 | 2.042B |
| October 23, 2026 | 2.031B |
| October 22, 2026 | 2.047B |
| October 21, 2026 | 2.023B |
| October 20, 2026 | 1.937B |
| October 19, 2026 | 1.838B |
| October 16, 2026 | 1.801B |
| October 15, 2026 | 1.853B |
| October 14, 2026 | 1.783B |
| October 13, 2026 | 1.804B |
| October 12, 2026 | 1.823B |
| October 09, 2026 | 1.856B |
| October 08, 2026 | 1.818B |
| October 07, 2026 | 1.909B |
| October 06, 2026 | 1.846B |
| October 05, 2026 | 1.886B |
| October 02, 2026 | 1.810B |
| October 01, 2026 | 1.868B |
| September 30, 2026 | 1.906B |
| September 29, 2026 | 1.957B |
| September 28, 2026 | 1.952B |
| September 25, 2026 | 1.908B |
| September 24, 2026 | 1.929B |
| September 23, 2026 | 1.979B |
| Date | Value |
|---|---|
| September 22, 2026 | 1.984B |
| September 21, 2026 | 1.929B |
| September 18, 2026 | 1.912B |
| September 17, 2026 | 1.978B |
| September 16, 2026 | 1.888B |
| September 15, 2026 | 1.875B |
| September 14, 2026 | 1.932B |
| September 11, 2026 | 1.888B |
| September 10, 2026 | 1.902B |
| September 09, 2026 | 1.954B |
| September 08, 2026 | 2.023B |
| September 04, 2026 | 2.101B |
| September 03, 2026 | 2.152B |
| September 02, 2026 | 2.234B |
| September 01, 2026 | 2.135B |
| August 31, 2026 | 2.116B |
| August 28, 2026 | 2.034B |
| August 27, 2026 | 2.088B |
| August 26, 2026 | 2.109B |
| August 25, 2026 | 1.977B |
| August 24, 2026 | 2.070B |
| August 21, 2026 | 2.063B |
| August 20, 2026 | 1.912B |
| August 19, 2026 | 1.958B |
| August 18, 2026 | 1.876B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AbbVie, Inc. | 506.00B |
| Aprea Therapeutics, Inc. | 6.666M |
| ACADIA Pharmaceuticals, Inc. | 3.495B |
| Alnylam Pharmaceuticals, Inc. | 31.09B |
| Anika Therapeutics, Inc. | 287.87M |
Market Cap Related Metrics
| PS Ratio | 58.09 |
| PEG Ratio | -0.1358 |
| Price to Book Value | 25.85 |
| Price | 28.87 |
| Earnings Yield | -6.98% |
| PEGY Ratio | -0.1358 |